It was demonstrated that the treatment with LSD1 inhibitors of cells of Acute Promyelocytic Leukemia (APL), a subtype of AML, does not induce growth arrest but increase sensitivity of the same cells to physiological concentrations of RA (Binda et al., 2010). This evidence concerns the gene KDM1A and acute myeloid leukemia.